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While antimicrobial resistance (AMR) continues to be a major public health problem in Paki-
stan, data regarding trends of resistance among pathogenic bacteria remains scarce, with
few studies presenting long-term trends in AMR. This study was therefore designed to ana-
lyze long-term AMR trends at a national level in Pakistan. We report here results of a com-
prehensive analysis of resistance, among pathogens isolated from blood and cerebrospinal
fluid (CSF), between 2011 and 2015. Susceptibility data was obtained from a local labora-
tory with collection points all across Pakistan (Chughtai Laboratory). Resistance proportions
to most commonly used antimicrobials were calculated for each pathogen over a period of
five years. While Acinetobacter species demonstrated highest resistance rates to all tested
antimicrobials, a sharp increase in carbapenem resistance was the most noticeable (50%-
95%) between 2011–2015. Our results also highlight the presence of third and fourth gener-
ation cephalosporins resistance in Salmonella enterica serovar Typhi in Pakistan. Interest-
ingly, where rise in AMR was being observed in some major invasive pathogens,
decreasing resistance trends were observed in Staphylococcus aureus, against commonly
used antimicrobials. Overall pathogens isolated from blood and CSF between 2011–2015,
showed an increase in resistance towards commonly used antimicrobials.
Introduction
The use of broad-spectrum antimicrobials for treatment of invasive infections, defined as blood-
stream and cerebrospinal fluid (CSF) infections, has resulted in an increase in antimicrobial
resistance (AMR). As a consequence, the treatment of such infections is becoming increasingly
difficult leading to treatment failures and increased mortality. Availability of over the counter
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drugs in developing countries such as Pakistan has led to the epidemic of AMR in these coun-
tries. Indiscriminate usage of antimicrobials exerts an increased selection pressure on the bacte-
rial population resulting in accelerated emergence of AMR [1]. Recent estimates suggested that
invasive infections, in particular antimicrobial resistant invasive infections, account for 5.3 mil-
lion deaths around the world annually. A significant proportion of these deaths occurs in low to
middle income countries (LMIC) such as Pakistan [2]. While developing countries are battling
an accelerated spread of AMR, developed countries are also experiencing the same trend. In the
United States between 1999 and 2012, 47.9% Acinetobacter baumanii were carbapenem resis-
tant, 68.4% Staphylococcus epidermidis were ciprofloxacin resistant, and 13.7% Escherichia coli
(E. coli) were β-lactam resistant [3–5]. Furthermore, a similar resistance landscape had emerged
in Canada between 2007 and 2011, where 27% of E.coli were resistant to ciprofloxacin, 19.3%
Staphylococcus aureus (S. aureus) were resistant to methicillin, and 16.8% Streptococcus pneumo-
niae (S. pneumoniae) were resistant to penicillin [6].
Unavailability of reliable data in the developing countries like Pakistan, makes it difficult to
develop efficient methods to monitor and control AMR [1]. The limited number of studies
undertaken to investigate resistance in Pakistan indicate that most of the pathogens are resis-
tant to commonly used antibiotics. For instance, between 1997 and 2014, 91% of E. coli were
reported to be resistant to amikacin, while 91.7% Salmonella enterica serovar Typhi (S. Typhi)
were fluoroquinolone resistant, and 90.9% Acinetobacter species were imipenem resistant [7–
9]. These studies indicate that AMR poses a burgeoning public health problem in Pakistan and
highlights the need of an in-depth assessment of AMR situation.
Towards this goal, the present study examined AMR data from a large diagnostic lab to iden-
tify (i) pathogens that are most commonly isolated from blood and CSF cultures in Pakistan,
(ii) the patterns of resistance amongst these pathogens, and (iii) their co-resistance trends.
Materials and methods
For this retrospective cross-sectional study, AMR data on pathogens isolated between 2011–
2015 and their antimicrobial susceptibilities were obtained from Chughtai Lab (CL), a local
diagnostic facility with over 180 collection centers in 60 cities of Pakistan. Standard biochemi-
cal tests and Analytical Profile Index (API) identification kits (BioMerieux) [10] were used to
identify bacterial species at CL. Antimicrobial susceptibility testing was done using disc diffu-
sion method following Clinical Laboratory & Standards Institute (CLSI) guidelines [11].
Data on positive cultures were obtained from an electronic database containing patients’
reports. Information obtained on each case included: (1) patient’s age, (2) patient’s sex, (3)
year of sample collection, (4) specimen source, (5) city in which the sample was drawn, (6) iso-
lated pathogen in the positive culture, and (7) susceptibility results (defined as susceptible,
intermediate, or resistant).
Of a total of 3092 cases, datasets with missing information on age (n = 17) and sex (n = 2)
were excluded from the study. Cases with information on pathogens isolated from sites other
than blood and CSF (n = 5) were also excluded from the dataset (Fig 1). Most commonly iso-
lated microorganisms from blood and CSF cultures were identified and used for all later analy-
sis. Microorganisms that demonstrated low frequency of isolation and were found in less than
100 samples were also eliminated from the analysis. Pathogens were stratified by year of sam-
ple collection and patients’ age (<5 years, 6–18 years, 19–45 years, 46–65 years, and 65<
years), and patients’ sex. For each case, intermediate resistance was considered as resistant.
Susceptibility for all tested antimicrobials was examined and reported in each species sepa-
rately. The bacterial species analyzed included E. coli, Acinetobacter species, S. aureus, and S.
Typhi.
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Fig 1. Flow of cases. Flow of the cases through the study has been shown.
https://doi.org/10.1371/journal.pone.0250226.g001
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Statistical analysis
Statistical analyses were performed using IBM SPSS statistics 22 (SPSS Inc., Chicago, Ill., USA).
SAS university edition software (Cary, NC: SAS Institute Inc) was employed to perform Cochran
Armitage test for trends. Figures were plotted using Circa software (www.omgenomics.com).
P-value of<0.05 was considered significant for all statistical analyses. Frequency of cases was cal-
culated by pathogens, by age and sex of patients, site of infection, and year of isolation using uni-
variate analysis. Unadjusted resistance rates in pathogens were determined over age groups, sex,
and year of isolation using univariate analysis. As the number of isolates varied annually
throughout the study period, proportions of the resistant pathogens were evaluated to normalize
the data. The proportions of resistant isolates were examined over age and sex respectively using
Fisher’s exact test, with Bonferroni corrections. Cochran Armitage test for trends was used to
investigate trends of AMR over time. Pairwise resistance (referred to as co-resistance) trends
were examined using chi-square test of independence. For significantly associated pairwise resis-
tance, binary logistic regression was used to calculate odds ratios, which outlined odd of resis-
tance to one antimicrobial given resistance to another antimicrobial. Antimicrobials with an
overall resistance above 1.5% were plotted in a Circos-based AMR map for each pathogen.
Results
Geographical, temporal, and demographical distribution of participants
Burden of invasive infections vary between different geographic regions as well as patients’
demographics [2, 12]. Hence, we wanted to profile the distribution of bacterial pathogens iso-
lated from blood and CSF cultures over patients’ demographics, geographic location and year
of isolation. Results of univariate analysis of demographic distribution of pathogens associated
with invasive infections and the phenotypic characteristics of such pathogens, are presented in
Table 1.
A total of 3068 microorganisms were isolated from blood and CSF cultures between 2011
and 2015. These cases were reported from 44 cities, from all four provinces of Pakistan, how-
ever, majority of cases were reported from 13 cities, whereas the remaining 31 cities reported
less than 11 cases. The median number of cases from any given city was 4 with an interquartile
range of 2–15. Analysis by province indicated that highest number of cases were reported from
Punjab (87.9%), followed by Khyber Pakhtunkhwa (11%), Sindh (1%) and Baluchistan
(0.033%). Within Punjab most (60.5%) of reported cases were from the city of Lahore, which is
the most populous city of Punjab followed by Faisalabad (18.3%) and Abbottabad (8.3%).
Detailed distribution of cases over geographic location is given in the S1 Table.
Temporal and demographical distribution of pathogens frequently isolated
from blood and CSF cultures
Distribution of isolates by patient characteristics (age and sex) and by year is given in Table 2.
Previous studies have shown that the incidence rates of pathogen-specific invasive infections
fluctuate on the basis of their temporal, spatial, and demographical characteristics [13]. Hence,
the next logical step was to determine the distribution patterns of pathogens isolated from
blood and CSF specimens. To investigate the temporal and demographical distribution of the
bacterial species, univariate analyses were performed. Over 75% of these pathogens were from
one of the seven most common bacterial species. These included CoNS (41.7%), E. coli
(10.6%), Stenotrophomonas. maltophilia (S. maltophilia) (6.2%), Acinetobacter species (6.2%),
S. Typhi (6.1%), S. aureus (5.9%), and Klebseilla pneumoniae (K. pneumoniae) (5%). Since data
was collected from a diagnostic laboratory, it was difficult to obtain data on patient
PLOS ONE Antimicrobial resistance in Pakistan
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characteristics such as clinical manifestation as well as mortality and morbidity rates for
CoNS. Therefore, samples containing CoNS were eliminated from the study (please see discus-
sion for further information on CoNS in Pakistan).
Antimicrobial resistance (AMR) trends in pathogens isolated from blood and CSF cul-
tures. Variations in the treatment approaches of physicians within a geographical location,
patients’ compliance, and the ability of pathogens to acquire and disseminate resistance,
impact resistance trends in different pathogens [14]. The ability of resistant pathogens to cause
infections is also dependent on host-related factors including age, gender, and co-morbidities
[15]. Towards this, we determined temporal and demographical AMR trends in pathogens
most frequently isolated from blood and CSF. Susceptibility data was not available for all years
throughout the study period on S. maltophilia and K. pneumoniae, therefore these two patho-
gens were excluded from the analysis. Moreover, in the absence of clinical data on patients to
support CoNS role in disease manifestation, CoNS was taken out of the downstream analysis.
Each of the remaining four pathogens were analyzed separately. For each isolate, susceptibility
data for all antimicrobials was not available. To account for missing values, available case
approach was employed to analyze resistance trends for each antimicrobial. As a result, the
number of data points (n) varied between analyses involving different antimicrobials in a
Table 1. Attributes of pathogens isolated from blood and cerebrospinal fluid between 2011–2015 in Pakistan.

























No information 3 (.1%)
Phenotypic characters/Gram Staining
Gram-positive bacteria 1433 (46.7%)
Gram-negative bacteria 1635 (53.3%)
https://doi.org/10.1371/journal.pone.0250226.t001
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pathogen. Tables 3–6 and Figs 2–5 demonstrate resistance trends in E. coli, Acinetobacter spe-
cies, S. Typhi and S. aureus.
To determine the association between age and sex and trends of antimicrobial resistance, the
frequency of isolation of resistance pathogen was calculated by age and sex. The sex-wise com-
parisons showed that the rate of isolation of resistant gram-negative pathogens were indepen-
dent of patients’ sex. Evaluation of age-wise resistance trends highlighted that rate of isolation of
resistant pathogens is age dependent in that children under 5 years of age had a higher rate of
isolation of E. coli resistant to fluoroquinolones as compared to the elderly (Table 3 and Fig 2).
Contrasting trend was observed for amikacin, piperacillin-tazobactam, cefoperazone-sulbactam
and carbapenem resistance in E. coli where we observed that children and young adults had a
higher rate of isolation of resistant strains compared to the elderly (Table 3 and Fig 2). Our
results have shown a similar trend for cefoperazone-sulbactam resistance in Acinetobacter spe-
cies–children under 5 years of age had higher rate of isolation of cefoperazone-sulbactam resis-
tant Acinetobacter species strains as compared to young adults and elderly (Table 4 and Fig 3).
We have also reported that S. Typhi isolated from adults between 18 to 45 years of age had a
higher proportion of Nalidixic acid resistance as compared to those isolated from children
under 5 years of age (Table 5 and Fig 4).
We then assessed temporal antimicrobial resistance trends in these pathogens using
Cochran Armitage test for trends. Our results show that among gram-negative organisms, E.
coli, demonstrated increasing resistance trend to fluoroquinolones, in that a sharp increase
from 50–74% was reported between 2011 and 2015 (Table 3 and Fig 2). Moreover, an increas-
ing resistance trend against cefipime, a fourth-generation cephalosporin, was also observed in
E. coli (Table 3 and Fig 2). While increasing resistance rates were observed for most of the
tested antimicrobials, we found decreasing resistance trends against amikacin and gentamicin
in E. coli (Table 3 and Fig 2). The most alarming trends were observed for Acinetobacter spe-
cies (Table 4 and Fig 3), which was found to be resistant to almost all antibiotics. Among these
resistance trends, the most notable was the steep increase in carbapenem resistance from 50%
in 2011 to 95.5% in 2015 (Table 4 and Fig 3). Between 2011 and 2015 in S. Typhi, our results
have demonstrated an increasing resistance trend against fluoroquinolones with resistance
Table 2. Profile of common bacterial species isolated from blood and cerebrospinal fluid (CSF) cultures with corresponding demographical and temporal
distribution.
Organism Age (years) Sex Year Total




















































































































































Data are n (% isolates in a column). Bacterial species with relative frequency above 5% are shown.in the table.
https://doi.org/10.1371/journal.pone.0250226.t002
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Fig 2. Antimicrobial resistance in Escherichia coli (E. coli). A: Each section of the diagram represents the resistance observed in E. coli against the
antibiotic. Size of each section is proportional to the proportion of E. coli resistant to the antibiotic over the study period. Antibiotics of the same
class are shown in similar colors. B: Line graphs show temporal trends of proportion of resistant E. coli in a clockwise direction from 2011 to 2015.
C: Bar charts show the comparison of susceptibility to resistant strains in patients of different age groups. Moving from out to inward, bars
represent proportion of resistant E. coli reported in children<5 years of age, young adults between 6 to 18 years, middle aged 19 to 45 years old, 45
to 65 years old patients, and elderly over 65 years of age, respectively. D: Gender-wise comparison to susceptibility to resistant E. coli is shown in
form bars. Outer circle and inner circle shows proportion of resistant E. coli isolated from women vs. men, respectively. E: For co-resistance
analysis, antibiotics belonging to the same class with same susceptibility profile for all isolates of E. coli were merged into a single variable. F:
Proportion of E. coli isolates resistant to one antimicrobial resistant to another antimicrobial are shown in the connections. The area covered by the
connection on E is proportional to the level of co-resistance observed. Co-resistance proportions were scaled down to 1/15th of the actual overlap
for visualization. Abbreviations: AMI: Amikacin, GEN: Gentamicin, TOB: Tobramycin, IMI: Imipenem, MER: Meropenem, CPL: Cephalexin,
CPD: Cephradine, CFC: Cefaclor, CFU: Cefuroxime, CFT: Cefotaxime, CFD: Ceftazidime, CFN: Ceftriaxone, CFX: Cefixime, CPZ: Cefoperazone,
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rates reaching up to 60% in 2015. Additionally, existing trends showed resistance to third and
emergence of resistance to fourth generation cephalosporins in S. Typhi (Table 5 and Fig 4).
Surprisingly, we did not observe any increasing resistance trend against the tested antimi-
crobials in S. aureus. Unlike other pathogens, a decreasing resistance trend to amikacin, doxy-
cycline, and trimethoprim-sulfamethoxazole was observed in S. aureus (Table 6 and Fig 5).
Detailed AMR trends in S. aureus have been tabulated in Table 6 and shown in Fig 5.
Co-resistance trends in pathogens isolated from blood and CSF cultures
Multidrug resistance (MDR) has emerged as a major public health problem globally as well as
in Pakistan. Co-resistance to multiple drugs emerges with the selection of strains which are
resistant to multiple antimicrobials. Clonal expansion of MDR clones is faster as compared to
strains resistant to a single antimicrobial [16]. Hence, it is important to identify those antimi-
crobials, which do not exhibit resistance with any other type of antimicrobials.
To investigate this, antimicrobials belonging to the same class and exhibiting identical resis-
tance profiles in isolates of a given species were merged and entries with missing data were
excluded. Chi-square test was used to identify patterns of co-resistance in each pathogen and
these patterns are tabulated in Tables 7 and S2–S5. Evaluation of E. coli showed that resistance
against all antimicrobials was significantly associated except β-lactams, aminoglycosides, fluo-
roquinolones, and tetracycline. Resistance against these four antimicrobials in E. coli was
found to be independent of resistance against other antimicrobials (Table 7 and Fig 2). We
then evaluated Acinetobacter species and our results showed that cefoperazone-sulbactam
resistance is not significantly associated with resistance against aminoglycosides, trimetho-
prim-sulfamethoxazole and tetracycline (Table 7 and Fig 3). For S. Typhi, we only detected a
significant co-resistance between nalidixic acid and fluoroquinolones (Table 7 and Fig 4).
Analysis of S. aureus showed that penicillin resistance was not associated with resistance
against any other antimicrobials. Furthermore, doxycycline resistance in S. aureus was found
to be independent of resistance to all antimicrobials except macrolides and tobramycin
(Table 7 and Fig 5). The co-resistance proportions, p-values, and associated odds ratios for all
tested antimicrobials are provided in Tables 7 and S2–S5. The co-resistance trends for E. coli,
Acinetobacter species, S. Typhi, and S. aureus are presented in Figs 2–5.
Discussion
Antimicrobial resistance (AMR) has emerged as a major public health concern in both devel-
oping and developed countries. Continuous surveillance of AMR has been recommended by
World Health Organization (WHO) as a necessary step for controlling emergence of resistance
as well as infections caused by resistant pathogens [17]. Despite this urgent need to investigate
AMR trends, only a handful of studies till date have reported resistance trends in pathogens
isolated from blood and CSF cultures in Pakistan [18, 19]. The current study stands to fill this
gap in knowledge of AMR patterns and trends in these bacterial pathogens at a national scale.
For that, we undertook a retrospective analysis of AMR of pathogens isolated from clinical
specimens of blood and CSF. To the best of our knowledge, this study is the first of its kind in
Pakistan providing both demographic and temporal AMR trends in major pathogens from
blood and CSF cultures. Previously published results have been limited by the number of par-
ticipants the sample size and analysis. Data presented in this report provides a more in-depth
CFP: Cefepime, CPZ-S: Cefoperazone-Sulbactam, PIP-T: Piperacillin-Tazobactam, AMX-C: Amoxicillin-Clavulanic acid, AMP-S: Ampicillin-
Sulbactam, CIP: Ciprofloxacin, LEV: Levofloxacin, OFL: Ofloxacin, MOX: Moxifloxacin, AZT: Aztreonam, TRI-S: Trime-Sulphamethoxazole, and
DOX: Doxycycline.
https://doi.org/10.1371/journal.pone.0250226.g002
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Fig 3. Antimicrobial resistance in Acinetobacter. A: Each section of the diagram represents the resistance observed in Acinetobacter species against the
antibiotic. Size of each section is proportional to the proportion of Acinetobacter species resistant to the antibiotic over the study period. Antibiotics of the
same class are shown in similar colors. B: Line graphs show temporal trends of proportion of resistant Acinetobacter species in a clockwise direction from
2011 to 2015. C: Bar charts show the comparison of susceptibility to resistant isolates in patients of different age groups. Moving from out to inward, bars
represent proportion of resistant Acinetobacter species reported in children<5 years of age, young adults between 6 to 18 years, middle aged 19 to 45
years old, 45 to 65 years old patients, and elderly over 65 years of age, respectively. D: Gender-wise comparison to susceptibility to resistant Acinetobacter
species is shown in form bars. Outer circle and inner circle shows proportion of resistant Acinetobacter species isolated from women vs. men,
respectively. E: For co-resistance analysis, antibiotics belonging to the same class with same susceptibility profile for all isolates of E. coli were merged into
a single variable. F: Proportion Acinetobacter species isolates resistant to one antimicrobial resistant to another antimicrobial are shown in the
connections. The area covered by the connection on E is proportional to the level of co-resistance observed. Co-resistance proportions were scaled down
to 1/10th of the actual overlap for visualization. Abbreviations: DOX: Doxycycline, TRI-S: Trime-Sulphamethoxazole, PIP-T: Piperacillin-Tazobactam,
AMP-S: Ampicillin-Sulbactam, AMX-C: Amoxicillin-Clavulanic acid, CIP: Ciprofloxacin, LEV: Levofloxacin, OFL: Ofloxacin, MOX: Moxifloxacin, CFN:
Ceftriaxone, CFD: Ceftazidime, CFT: Cefotaxime, CPZ: Cefoperazone, CFX: Cefixime, CFP: Cefepime, CPZ-S: Cefoperazone-Sulbactam, IMI: Imipenem,
MER: Meropenem, TOB: Tobramycin, GEN: Gentamicin, and AMI: Amikacin.
https://doi.org/10.1371/journal.pone.0250226.g003
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Fig 4. Antimicrobial resistance in Salmonella enterica serovar Typhi (S. Typhi). A: Each section of the diagram represents the resistance observed in
S. Typhi against the antibiotic. Size of each section is proportional to the proportion of S. Typhi resistant to the antibiotic over the study period.
Antibiotics of the same class are shown in similar colors. B: Line graphs show temporal trends of proportion of resistant S. Typhi in a clockwise
direction from 2011 to 2015. C: Bar charts show the comparison of susceptibility to resistant isolates in patients of different age groups. Moving from
out to inward, bars represent proportion of resistant S. Typhi reported in children<5 years of age, young adults between 6 to 18 years, and middle aged
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analysis of antimicrobial resistance. While most of the previous studies were cross-sectional
presenting resistance at single time point, our long-term analysis presents alterations in resis-
tance patterns over five years.
Our results show that CoNS was the most frequently isolated pathogen from invasive iso-
lates which is consistent with previous studies in southeast Asia [20]. However, as we did not
have information on the clinical manifestation of these cases and they may have been skin con-
taminants, we removed CoNS from the downstream analysis. Two of the most probable rea-
sons for high rate of isolation of CoNS in Pakistan could be poor clinical sample management
and presence of contaminants on surfaces [21].
In accordance with international reports, our data also reflects emergence of antimicrobial
resistance in Pakistan, where pathogens are resistant to most commonly used antimicrobials
[1, 3, 22]. Our analysis showed a wide distribution of resistant pathogen over 44 cities of Paki-
stan, however most of our observations were from the province of Punjab, which could be
because the facility is primarily located in Punjab. No significant association was observed
when comparisons were made by sex, indicating that both male and female are equally suscep-
tible to infections caused by resistant pathogens. Similarly, no significant association between
a sex and a specific pathogen was observed. However, we did observe a significant association
between rates of isolation of resistant pathogens with age, younger children and elderly were at
a higher risk of infections by drug resistant pathogens. This observation is in line with previous
findings where infections with resistant pathogens were found to be associated with a children
and elderly [23–25]. The most likely explanation for these observations is the increase rates of
infections in both elderly and children. The observed increase susceptibility to infections in
children and elderly is due to poor immune responses. As a result antimicrobials are frequently
and empirically used in both children and elderly resulting in increased rates of infections by
resistant pathogens.
Upper respiratory tract infections and gastrointestinal tract infections are the most frequent
cause of doctors visit for children and elderly in Pakistan. Such infections are most often
treated empirically by broad spectrum antibiotics without performing culture sensitivity, lead-
ing to development of resistance in both, the resident bacteria and infecting pathogen. Com-
parison of rates of isolation of different invasive pathogens indicated an increase in rate of
isolation of S. maltophilia between 2013 and 2014. Stenotrophomonas maltophilia, previously
known as Pseudomonas maltophilia primarily cause infections in immune compromised indi-
viduals. Together with Pseudomonas aeruginosa and Acinetobacter baumannii, S.maltophilia is
an important cause of healthcare-associated infections. Moreover, A. baumannii and S. malto-
philia have also been shown to co-exist, causing multi drug resistant polymicrobial infections
in hospitalized patients. Most common source of these infections are contaminated endo-
scopes and dialysis machines where S. maltophilia and A. baumannii has been shown to form
biofilms [21, 26–29].
Another salient observation of our study is the rapid rise of carbapenems resistance among
Acinetobacter species (CRA) (from 50% to 95% between 2011 and 2015) in Pakistan. This is in
19 to 45 years old, respectively. D: Gender-wise comparison to susceptibility to resistant S. Typhi is shown in form bars. Outer circle and inner circle
show proportion of resistant S. Typhi isolated from women vs. men, respectively. E: For co-resistance analysis, antibiotics belonging to the same class
with same susceptibility profile for all isolates of E. coli were merged into a single variable. F: Proportion S. Typhi isolates resistant to one antimicrobial
resistant to another antimicrobial are shown in the connections. The area covered by the connection on E is proportional to the level of co-resistance
observed. Co-resistance proportions were scaled down to 1/10th of the actual overlap for visualization. Abbreviations: CFN: Ceftriaxone, CFD:
Ceftazidime, CFT: Cefotaxime, CPZ: Cefoperazone, CFX: Cefixime, CFP: Cefepime, CIP: Ciprofloxacin, LEV: Levofloxacin, OFL: Ofloxacin, MOX:
Moxifloxacin, NAL-A: Nalidixic acid, AMP-S: Ampicillin-Sulbactam, AMX-C: Amoxicillin-Clavulanic acid, AMP: Ampicillin, AMX: Amoxicillin, and
TRI-S: Trime-Sulphamethoxazole.
https://doi.org/10.1371/journal.pone.0250226.g004
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Fig 5. Antimicrobial resistance in Staphylococcus aureus (S. aureus). A: Each section of the diagram represents the resistance observed in S. aureus
against the antibiotic. Size of each section is proportional to the proportion of S. aureus resistant to the antibiotic over the study period. Antibiotics of
the same class are shown in similar colors. B: Line graphs show temporal trends of proportion of resistant S. aureus in a clockwise direction from 2011
to 2015. C: Bar charts show the comparison of susceptibility to resistant strains in patients of different age groups. Moving from out to inward, bars
represent proportion of resistant S. aureus reported children in<5 years of age, young adults between 6 to 18 years, middle aged 19 to 45 years old, 45
to 65 years old patients, and elderly over 65 years of age, respectively. D: Gender-wise comparison to susceptibility to resistant S. aureus is shown in
form bars. Outer circle and inner circle show proportion of resistant S. aureus isolated from women vs. men, respectively. E: For co-resistance
analysis, antibiotics belonging to the same class with same susceptibility profile for all isolates of S. aureus were merged into a single variable. F:
Proportion of S. aureus isolates resistant to one antimicrobial resistant to another antimicrobial are shown in the connections. The area covered by the
connection on E is proportional to the level of co-resistance observed. Co-resistance proportions were scaled down to 1/10th of the actual overlap for
visualization. Abbreviations: AMI: Amikacin, GEN: Gentamicin, TOB: Tobramycin, AMP: Ampicillin, AMX: Amoxicillin, IMI: Imipenem, MER:
Meropenem, CPL: Cephalexin, CPD: Cephradine, CFC: Cefaclor, CFU: Cefuroxime, CFT: Cefotaxime, CFD: Ceftazidime, CFN: Ceftriaxone, CFX:
Cefixime, CPZ: Cefoperazone, CFP: Cefepime, AMX-C: Amoxicillin-Clavulanic acid, AMP-S: Ampicillin-Sulbactam, CIP: Ciprofloxacin, LEV:
Levofloxacin, OFL: Ofloxacin, MOX: Moxifloxacin, CLI: Clindamycin, AZI: Azithromycin, ERY: Erythromycin, TRI-S: Trime-Sulphamethoxazole,
and DOX: Doxycycline.
https://doi.org/10.1371/journal.pone.0250226.g005
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Table 7. Selected co-resistance trends in pathogens isolated from blood and cerebrospinal fluid (CSF) cultures in Pakistan (2011–2015).
Pathogen Antimicrobial 1 Number of isolates resistant
to antimicrobial 1 & 2/
Number of isolates resistant
to antimicrobial 1 (%)
Number of isolates resistant
to antimicrobial 1 & 2/
Number of isolates resistant
to antimicrobial 2 (%)
P for
difference
Odds ratio 95% CI) Antimicrobial 2
Acinetobacter Cefoperazone-
sulbactam
54/ 54 (100) 54/ 104 (51.9) 0.118 NA Piperacillin-
tazobactam
52/ 54 (96.3) 52/ 100 (52) 0.2702 3.25 (0.63–16.88) Amikacin
42/ 54 (77.8) 42/ 79 (53.2) 0.2777 1.61 (0.68–3.8) Tobramycin
53/ 54 (98.1) 53/ 103 (51.5) 0.3632 4.24 (0.46–39.24) Gentamicin
29/ 54 (53.7) 29/ 55 (52.7) 0.5636 1.25 (0.59–2.66) Doxycycline
48/ 54 (88.9) 48/ 96 (50) 1 1 (0.3–3.32) Trimethoprim-
sulphamethoxazole
Cephalosporin 79/ 106 (74.5) 79/ 79 (100) 0.0703 NA Tobramycin
103/ 106 (97.2) 103/ 104 (99) 0.073 34.33 (1.71–689.68) Piperacillin-
tazobactam
99/ 106 (93.4) 99/ 100 (99) 0.1433 14.14 (0.8–250.9) Amikacin
55/ 106 (51.9) 55/ 55 (100) 0.2385 NA Doxycycline
54/ 106 (50.9) 54/ 54 (100) 0.4953 NA Cefoperazone-
sulbactam
Carbapenem 78/ 104 (75) 78/ 79 (98.7) 0.0583 9 (0.9–90.33) Tobramycin
103/ 104 (99) 103/ 106 (97.2) 0.073 34.33 (1.71–689.68) Cephalosporin
54/ 104 (51.9) 54/ 54 (100) 0.118 NA Cefoperazone-
sulbactam
54/ 104 (51.9) 54/ 55 (98.2) 0.3587 3.24 (0.33–32.18) Doxycycline
Piperacillin-
tazobactam
78/ 104 (75) 78/ 79 (98.7) 0.0583 9 (0.9–90.33) Tobramycin
54/ 104 (51.9) 54/ 55 (98.2) 0.3587 3.24 (0.33–32.18) Doxycycline
Doxycycline 51/ 55(92.7) 51/ 96(53.1) 0.196 2.27(0.64–8.03) Trimethoprim-
sulphamethoxazole
Tobramycin 72/ 79(91.1) 72/ 96(75) 0.2984 2.14(0.62–7.38) Trimethoprim-
sulphamethoxazole
Escherichia coli Carbapenem 3/ 6 (50) 3/ 133 (2.3) 0.1118 0.25 (0.05–1.32) Doxycycline
6/ 6 (100) 6/ 119 (5) 0.181 NA Tobramycin
5/ 6 (83.3) 5/ 96 (5.2) 0.2367 3.96 (0.45–34.62) Gentamicin
6/ 6 (100) 6/ 137 (4.4) 0.3604 NA 4th generation
cephalosporin
6/ 6 (100) 6/ 139 (4.3) 0.3732 NA Trimethoprim-
sulphamethoxazole
6/ 6 (100) 6/ 144 (4.2) 0.5935 NA 3rd generation
cephalosporin
6/ 6 (100) 6/ 145 (4.1) 0.5958 NA Aztreonam
6/ 6 (100) 6/ 145 (4.1) 0.5958 NA Aztreonam
6/ 6 (100) 6/ 153 (3.9) 0.6462 NA Penicillin
6/ 6 (100) 6/ 153 (3.9) 0.6462 NA Penicillin & β-
lactamase inhibitor
6/ 6 (100) 6/ 154 (3.9) 0.6572 NA 2nd generation
cephalosporin
5/ 6 (83.3) 5/ 128 (3.9) 1 1.63 (0.18–14.33) Fluoroquinolone
(Continued)
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Table 7. (Continued)
Pathogen Antimicrobial 1 Number of isolates resistant
to antimicrobial 1 & 2/
Number of isolates resistant
to antimicrobial 1 (%)
Number of isolates resistant
to antimicrobial 1 & 2/
Number of isolates resistant
to antimicrobial 2 (%)
P for
difference
Odds ratio 95% CI) Antimicrobial 2
Cefoperazone-
sulbactam
12/ 15 (80) 12/ 96 (12.5) 0.0575 3.33 (0.9–12.28) Gentamicin
15/ 15 (100) 15/ 137 (10.9) 0.0772 1 (17–120) 4th generation
cephalosporin
15/ 15 (100) 15/ 144 (10.4) 0.1308 NA 3rd generation
cephalosporin
14/ 15 (93.3) 14/ 139 (10.1) 0.3139 3.25 (0.41–25.7) Trimethoprim-
sulphamethoxazole
15/ 15 (100) 15/ 153 (9.8) 0.3657 1 (17–136) Penicillin & β-
lactamase inhibitor
15/ 15 (100) 15/ 154 (9.7) 0.3665 1 (17–137) 2nd generation
cephalosporin
13/ 15 (86.7) 13/ 128 (10.2) 0.3665 2.2 (0.48–10.2) Fluoroquinolone
14/ 15 (93.3) 14/ 145 (9.7) 0.4817 2.46 (0.31–19.61) Aztreonam
11/ 15 (73.3) 11/ 133 (8.3) 0.7408 0.72 (0.22–2.42) Doxycycline
Piperacillin-
tazobactam
17/ 17 (100) 17/ 144 (11.8) 0.0795 NA 3rd generation
cephalosporin
13/ 17 (76.5) 13/ 96 (13.5) 0.0843 2.7 (0.84–8.66) Gentamicin
17/ 17 (100) 17/ 145 (11.7) 0.1351 1 (152–1) Aztreonam
16/ 17 (94.1) 16/ 139 (11.5) 0.2094 3.77 (0.48–29.61) Trimethoprim-
sulphamethoxazole
17/ 17 (100) 17/ 153 (11.1) 0.2284 1 (137–17) Penicillin & β-
lactamase inhibitor
17/ 17 (100) 17/ 154 (11) 0.2374 1 (137–0) 2nd generation
cephalosporin
15/ 17 (88.2) 15/ 128 (11.7) 0.2494 2.59 (0.57–11.83) Fluoroquinolone
14/ 17 (82.4) 14/ 133 (10.5) 0.7702 1.29 (0.35–4.77) Doxycycline
Amikacin 15/ 22(68.2) 15/ 133(11.3) 0.2613 0.53 (0.2–1.41) Doxycycline
21/ 22(95.5) 21/ 153(13.7) 0.4866 2.39 (0.3–19.02) Penicillin & β-
lactamase inhibitor
21/ 22(95.5) 21/ 154(13.6) 0.6957 2.21 (0.28–17.7) 2nd generation
cephalosporin
16/ 22(72.7) 16/ 128(12.5) 0.7238 0.83 (0.3–2.29) Fluoroquinolone
17/ 22(77.3) 17/ 137(12.4) 0.7703 0.77 (0.26–2.25) 4th generation
cephalosporin
18/ 22(81.8) 18/ 139(12.9) 1 0.97 (0.3–3.09) Trimethoprim-
sulphamethoxazole
19/ 22(86.4) 19/ 145(13.1) 1 1.06 (0.29–3.88) Aztreonam
19/ 22(86.4) 19/ 144(13.2) 1 1.11 (0.3–4.09) 3rd generation
cephalosporin




Penicillin 4/5 (80) 4/ 49 (8.1) 0.172 5.24 (0.567–48.55) Trimethoprim-
sulphamethoxazole
4/5 (80) 4/ 100 (4) 0.356 0.333 (.033–3.348) Nalidixic acid
4/5 (80) 4/ 86 (4.65) 1 1.073 (0.114–10.93) Fluoroquinolone
Trimethoprim-
sulphamethoxazole
46/49 (93.8) 46/100 (46) 0.51 1.704 (0.403–7.195) Nalidixic acid
39/49 (79.6) 39/86 (45.3) 1 1.079 (.427–2.727) Fluoroquinolone
(Continued)
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line with earlier CRA trends in Southeast Asian countries [30, 31]. This increase is concomi-
tant with the two-fold increase in carbapenem usage in Pakistan over the last decade [32, 33].
It is critical to note that carbapenems are one of the few last resort broad-spectrum antibiotics
recommended for treatment of sepsis in Pakistan [34] and emergence of CRA has further lim-
ited the therapeutic options. Only doxycycline and cefoperazone-sulbactam remain effective
against many of the Acinetobacter strains (Table 4). The persistent susceptibility to doxycycline
may be attributed to its limited usage in Acinetobacter infections treatment due to its bacterio-
static nature [35]. Further, while resistance against cefoperazone-sulbactam was found to be
on the rise (Table 4), a wider acquisition of resistance against it might require more time.
Additionally, Acinetobacter is an environmental pathogen found in the soil, the acquisition of
resistance therefore suggests inappropriate disposal of antimicrobials. To further explain this,
it is likely that unused or expired antimicrobials are being disposed of in a way that they are
available to environmental organisms resulting in emergence of resistance in such organism
[36, 37]. This situation provides policymakers with an opportunity to legislate regulated usage
of carbapenem, cefoperazone-sulbactam, and doxycycline in the country, and ensure proper
disposal of such antimicrobials from hospital systems. Developed countries like the US and the
UK have resorted to using colistin, polymixin B, and tigecycline for the treatment of CRA
infections [38, 39]. Susceptibility data against these antibiotics were not accounted for in this
study. Future studies should highlight the susceptibility patterns of Acinetobacter against colis-
tin, polymixin B, and tigecycline.
Another important finding of this study is the presence of third and fourth generation
cephalosporins resistance in S. Typhi. Recent studies have reported an incidence of third
generation resistant S. Typhi infections in Pakistan and neighboring countries [40, 41].
These antimicrobials are the drugs of choice for the empirical treatment of these infections
[42]. This suggests that treatment of these infections with cephalosporins will become inef-
fective. Case studies from Canada and the US have shown that these infections can success-
fully be treated with carbapenems and ceftriaxone-azithromycin combination [43].
However, it is highly likely that S. Typhi will acquire resistance against these antimicrobials
Table 7. (Continued)
Pathogen Antimicrobial 1 Number of isolates resistant
to antimicrobial 1 & 2/
Number of isolates resistant
to antimicrobial 1 (%)
Number of isolates resistant
to antimicrobial 1 & 2/
Number of isolates resistant
to antimicrobial 2 (%)
P for
difference
Odds ratio 95% CI) Antimicrobial 2
Staphylococcus
aureus
Doxycycline 7/ 24 (29.2) 7/ 16 (43.8) 0.0502 2.97 (0.97–9.14) Amikacin
11/ 24 (45.8) 11/ 31 (35.5) 0.0852 2.28 (0.88–5.92) Clindamycin
15/ 24 (62.5) 15/ 48 (31.3) 0.1273 2.07 (0.8–5.33) Macrolides
13/ 24 (54.2) 13/ 44 (29.5) 0.2935 1.64 (0.65–4.14) β-lactam (except
penicillin)
11/ 24 (45.8) 11/ 37 (29.7) 0.3475 1.56 (0.61–3.98) Gentamicin
12/ 24 (50) 12/ 47 (25.5) 0.8179 1.11 (0.44–2.8) Fluoroquinolone
Trimethoprim-
sulphamethoxazole
25/ 44 (56.8) 25/ 48 (52.1) 0.1612 1.77 (0.79–3.96) Macrolides
8/ 44 (18.2) 8/ 16 (50) 0.6538 1.28 (0.44–3.74) Amikacin
Penicillin 58/ 95 (61.1) 58/ 59 (98.3) 0.5613 3.14 (0.27–35.81) Tobramycin
Data are number of isolates resistant to both antimicrobials / number of isolates resistant to either antimicrobial 1 (in the case of R1) or antimicrobial 2 (in the case of
R1) (%). P-value for difference was calculated using Chi-square test. Odds-ratio was calculated using binary logistic regression and is listed with 95% confidence interval
(95% CI). Two-sided p-value has been reported.
https://doi.org/10.1371/journal.pone.0250226.t007
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in the short term. In the light of this, WHO has recommended large scale implementation
of Typbar-TCV, a typhoid vaccine, for the containment of S. Typhi infections in high risk
regions [42, 44]. Improved personal hygiene, handwashing, availability of clean drinking
water, and well cooked food lowers the risk of S. Typhi infections by 20% [42, 45]. The gov-
ernment should actively work towards implementing these suggestions to limit the spread
of drug resistant S. Typhi infections.
While AMR was rising in other major pathogens, we unexpectedly found decreasing resis-
tance rates against few major antimicrobials in S. aureus. This is in line with the reports on
incidence of antimicrobial resistant S. aureus infections worldwide [46, 47]. While the exact
reason for this decrease is yet to be identified, studies have suggested that it may be due to
improved infection control practices and improved antibiotic prescription guidelines [46].
The ability of S. aureus to excise resistance markers, out of its genome, in the absence of anti-
microbials may have played a role in the decreasing resistance as well. Excision of resistance
markers is associated with reduced metabolic cost and overall increase in the bacterial fitness
[46, 48, 49]. While the current resistance levels in S. aureus are low, continuous surveillance is
required to keep track of emerging resistance trends in this pathogen.
Study limitation
This study is limited in that two provinces, namely Baluchistan and Gilgit-Baltistan, were not
represented. The combined population of these two provinces constitutes less than 10% of the
population of and our sample was representative of two large provinces namely Punjab and
Sindh where 90% of Pakistani population resides. Therefore we can comfortably state that this
is the representative sample of the country. However, this does not exclude the need for per-
forming similar studies in areas such as Gilgit-Baltistan and Baluchistan [50]. However, excess-
ing data from these regions is difficult and adds to the limitations of our study. Next, while our
results have shown CoNS to be the most prevalent bacterial pathogen isolated from the blood
and CSF cultures, this can be explained by CoNS being a common skin contaminant. For the
purpose of this study, we have treated CoNS as a contaminant and not reported resistance
trends in CoNS. However, further studies need to be carried to determine the role of CoNS as
a potential bacteremia pathogen. Due to the unavailability of the patient characteristics we
were also limited in our analysis of the impact of comorbid conditions on the susceptibility to
invasive infections by resistant bacteria. Data regarding antimicrobial prescription practices
was also lacking, preventing us to determine the impact of prescription practices in a geo-
graphic region on emergence of resistance. Since a significant proportion of our patient popu-
lation was from Punjab and KPK, our analysis by geographic region was limited by lack of
power. Lastly, susceptibility data on last resort antibiotics, including colistin, polymixin B, and
linezolid, was not available. Susceptibility patterns of invasive pathogens to these antibiotics
still need to be carried out.
Conclusions
In this study we set out to determine resistance patterns in pathogens isolated from blood and
CSF cultures. We found that resistance has been at rise for several of these pathogens. Highest
resistance rates were observed in Acinetobacter species against all tested antimicrobials includ-
ing carbapenems. Resistance against 3rd and 4th generation cephalosporins has been reported
in S. Typhi during the study period. Policy makers should prioritize and expedite implementa-
tion of infection control practices and antimicrobial stewardship in the country to control the
emerging threat of AMR to public health.
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